Clinical Trials Browser

Phase 2 × OTHER_GOV × Biliary Tract Neoplasms × Clear all

NCT06654947 2024-12-16

A Single-arm, Open-label, Prospective Clinical Study of Surufatinib Combined With Immunotherapy and Chemotherapy for Unresectable or Metastatic Biliary Tract Cancer.

Phase 2 Not yet recruiting

Gastrointestinal

Biliary Tract Neoplasms

NCT04352023 2020-04-17

Analgesic Efficacy After Pancreatobiliary Surgery: Intravenous Versus Patient-controlled Epidural

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms, Pancreatic Neoplasms